1/7
08:00 am
snse
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
Medium
Report
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
12/27
01:05 am
snse
Sensei Biotherapeutics (NASDAQ:SNSE) was upgraded by analysts at
Wall St
Low
Report
Sensei Biotherapeutics (NASDAQ:SNSE) was upgraded by analysts at
Wall St
11/20
01:38 pm
snse
Sensei Biotherapeutics (NASDAQ:SNSE) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Sensei Biotherapeutics (NASDAQ:SNSE) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/14
07:30 am
snse
Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results
Medium
Report
Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results
10/30
12:05 pm
snse
Sensei Biotherapeutics (NASDAQ:SNSE) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
Medium
Report
Sensei Biotherapeutics (NASDAQ:SNSE) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
10/30
09:35 am
snse
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value [Yahoo! Finance]
Neutral
Report
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value [Yahoo! Finance]
10/30
09:00 am
snse
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value
Medium
Report
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value